Myriad Genetics Inc

MYGN•United States

Healthcare United States In Vitro & In Vivo Diagnostic SubstancesOptions Available

Need professional-grade analysis? Visit stockanalysis.com

$4.61

+0.66%

End of day

Market Cap

N/A

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	-1.98	2.02	-1.97	-1.37	-0.87	—	-0.91
Calmar	-22.20	6.44	-2.14	-1.36	-0.87	—	-1.70
Sharpe	-1.31	1.19	-1.48	-1.08	-0.60	—	-0.71
Omega	0.51	1.33	0.59	0.75	0.91	—	0.83
Martin	-34.40	12.66	-3.59	-2.57	-1.36	—	-2.46
Ulcer	0.83	6.83	21.04	25.11	38.72	—	24.78

Also Listed On

0K3W.LSE

London Stock Exchange · GBP

Myriad Genetics Inc (MYGN) Price Performance

Myriad Genetics Inc (MYGN) trades on United States in USD. The company is classified in the Healthcare sector under the In Vitro & In Vivo Diagnostic Substances industry. The stock currently trades at $4.61, up 0.66% from the previous close.

Over the past year, MYGN has traded between a low of $3.84 and a high of $9.22. The stock has lost 49.9% over this period. It is currently 50.0% below its 52-week high.

Company Info

Sector: Healthcare
Industry: In Vitro & In Vivo Diagnostic Substances
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): $837.60M
EBITDA: N/A
Profit Margin: -15.20%
EPS (TTM): N/A
Book Value: 701.10

Technical Indicators

52 Week High: $9.88
52 Week Low: $3.76
50 Day MA: $5.36
200 Day MA: $6.10
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: N/A